60 Degrees Pharmaceuticals Llc

This program provides access to an experimental drug called tafenoquine for immunocompromised adults who have a persistent Babesia infection that hasn't cleared with standard treatments. Patients take the drug orally, starting with daily doses and then switching to weekly doses, …

This study is testing whether adding an oral drug called tafenoquine to the standard antibiotic treatment helps hospitalized babesiosis patients get better faster. Babesiosis is a parasitic infection spread by ticks. Researchers will compare symptom recovery time in about 33 adul…

This study is testing whether the drug tafenoquine can help people with chronic babesiosis who suffer from severe, disabling fatigue. The main goal is to see if the treatment reduces fatigue levels and clears the Babesia parasite from the body. Researchers will enroll 40 adults a…